These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 9010576

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. New prospects in the treatment of indolent lymphomas with purine analogues.
    Cheson BD.
    Cancer J Sci Am; 1998 Jul; 4 Suppl 2():S27-36. PubMed ID: 9672772
    [Abstract] [Full Text] [Related]

  • 3. Fludarabine--present status and future developments in chronic lymphocytic leukemia and lymphoma.
    Keating MJ, McLaughlin P, Plunkett W, Robertson LE, O'Brien S, Gandhi V, Gregoire V, Yang L, Cabanillas F.
    Ann Oncol; 1994 Jul; 5 Suppl 2():79-83. PubMed ID: 8204523
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pentostatin (Nipent) and chlorambucil with granulocyte-macrophage colony-stimulating factor support for patients with previously untreated, treated, and fludarabine-refractory B-cell chronic lymphocytic leukemia.
    Waselenko JK, Grever MR, Beer M, Lucas MA, Byrd JC.
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):44-51. PubMed ID: 10877052
    [Abstract] [Full Text] [Related]

  • 8. Cladribine in the treatment of chronic lymphocytic leukemia.
    Robak T.
    Leuk Lymphoma; 2001 Feb; 40(5-6):551-64. PubMed ID: 11426528
    [Abstract] [Full Text] [Related]

  • 9. The expanding role of fludarabine in hematologic malignancies.
    Keating MJ, O'Brien S, Robertson LE, Kantarjian H, Dimopoulos M, McLaughlin P, Cabanillas F, Gregoire V, Li YY, Gandhi V.
    Leuk Lymphoma; 1994 Feb; 14 Suppl 2():11-6. PubMed ID: 7533576
    [Abstract] [Full Text] [Related]

  • 10. Fludarabine therapy in Waldenström's macroglobulinemia.
    Dimopoulos MA, O'Brien S, Kantarjian H, Pierce S, Delasalle K, Barlogie B, Alexanian R, Keating MJ.
    Am J Med; 1993 Jul; 95(1):49-52. PubMed ID: 8328496
    [Abstract] [Full Text] [Related]

  • 11. Purine analogs in the treatment of chronic lymphocytic leukemia.
    Pott C, Hiddemann W.
    Leukemia; 1997 Apr; 11 Suppl 2():S25-8. PubMed ID: 9178834
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Rituximab plus fludarabine and cyclophosphamide or other agents in chronic lymphocytic leukemia.
    Robak T, Lech-Maranda E, Robak P.
    Expert Rev Anticancer Ther; 2010 Oct; 10(10):1529-43. PubMed ID: 20942624
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Therapy of chronic lymphocytic leukemia with purine analogs and monoclonal antibodies.
    Robak T.
    Transfus Apher Sci; 2005 Feb; 32(1):33-44. PubMed ID: 15737872
    [Abstract] [Full Text] [Related]

  • 18. Fludarabine in Waldenstrom's macroglobulinemia.
    Souchet-Compain L, Nguyen S, Choquet S, Leblond V.
    Expert Rev Hematol; 2013 Jun; 6(3):229-37. PubMed ID: 23782076
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Treatment options in Waldenström's macroglobulinaemia: the role of the purine analogues.
    Owen RG.
    Expert Opin Pharmacother; 2001 Jun; 2(6):945-52. PubMed ID: 11585010
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.